aluates Reports

$ 0.0

Automative

Global Immune Thrombocytopenia Drugs Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-29L5860

Global Immune Thrombocytopenia Drugs Market Insights Forecast to 2028

BUY CHAPTERS

Global Immune Thrombocytopenia Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-29L5860

Report

December 2024

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

CSL Limited

Horizon Therapeutics plc

Merck& Co. Inc

Novartis

Rigel Pharmaceuticals Inc

Immune Thrombocytopenia Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Immune Thrombocytopenia Drugs Market

Thrombocytopenia is a condition characterized by abnormally low levels of thrombocytes, also known as platelets, in the blood.

Market Analysis and Insights: Global Immune Thrombocytopenia Drugs Market

The global Immune Thrombocytopenia Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Immune Thrombocytopenia Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Immune Thrombocytopenia Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Immune Thrombocytopenia Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immune Thrombocytopenia Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Immune Thrombocytopenia Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Immune Thrombocytopenia Drugs revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Immune Thrombocytopenia Drugs Market Report

Report Metric	Details
Report Name	Immune Thrombocytopenia Drugs Market
CAGR	5%
Segment by Type	Thrombopoietin Receptor Agonists (TPO-RAs) Corticosteroids Intravenous Immunoglobins (IVIGs) Other Drugs
Segment by Application	Biotechnology and Pharmaceutical Companies Hospitals and Diagnostic Centers Academic Institutes and Research Organizations
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen Inc., CSL Ltd., Horizon Therapeutics Plc, Merck & Co., Inc., Novartis AG, Rigel Pharmaceuticals Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Immune Thrombocytopenia Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immune Thrombocytopenia Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immune Thrombocytopenia Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Immune Thrombocytopenia Drugs Market report?

Ans: The main players in the Immune Thrombocytopenia Drugs Market are Amgen Inc., CSL Ltd., Horizon Therapeutics Plc, Merck & Co., Inc., Novartis AG, Rigel Pharmaceuticals Inc.

What are the Application segmentation covered in the Immune Thrombocytopenia Drugs Market report?

Ans: The Applications covered in the Immune Thrombocytopenia Drugs Market report are Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers, Academic Institutes and Research Organizations

What are the Type segmentation covered in the Immune Thrombocytopenia Drugs Market report?

Ans: The Types covered in the Immune Thrombocytopenia Drugs Market report are Thrombopoietin Receptor Agonists (TPO-RAs), Corticosteroids, Intravenous Immunoglobins (IVIGs), Other Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immune Thrombocytopenia Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Thrombopoietin Receptor Agonists (TPO-RAs)

1.2.3 Corticosteroids

1.2.4 Intravenous Immunoglobins (IVIGs)

1.2.5 Other Drugs

1.3 Market by Application

1.3.1 Global Immune Thrombocytopenia Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Biotechnology and Pharmaceutical Companies

1.3.3 Hospitals and Diagnostic Centers

1.3.4 Academic Institutes and Research Organizations

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Immune Thrombocytopenia Drugs Market Perspective (2019-2030)

2.2 Global Immune Thrombocytopenia Drugs Growth Trends by Region

2.2.1 Immune Thrombocytopenia Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Immune Thrombocytopenia Drugs Historic Market Size by Region (2019-2024)

2.2.3 Immune Thrombocytopenia Drugs Forecasted Market Size by Region (2025-2030)

2.3 Immune Thrombocytopenia Drugs Market Dynamics

2.3.1 Immune Thrombocytopenia Drugs Industry Trends

2.3.2 Immune Thrombocytopenia Drugs Market Drivers

2.3.3 Immune Thrombocytopenia Drugs Market Challenges

2.3.4 Immune Thrombocytopenia Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Immune Thrombocytopenia Drugs by Players

3.1.1 Global Immune Thrombocytopenia Drugs Revenue by Players (2019-2024)

3.1.2 Global Immune Thrombocytopenia Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Immune Thrombocytopenia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Immune Thrombocytopenia Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Immune Thrombocytopenia Drugs Market Concentration Ratio

3.4.1 Global Immune Thrombocytopenia Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immune Thrombocytopenia Drugs Revenue in 2023

3.5 Global Key Players of Immune Thrombocytopenia Drugs Head office and Area Served

3.6 Global Key Players of Immune Thrombocytopenia Drugs, Product and Application

3.7 Global Key Players of Immune Thrombocytopenia Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Immune Thrombocytopenia Drugs Breakdown Data by Type

4.1 Global Immune Thrombocytopenia Drugs Historic Market Size by Type (2019-2024)

4.2 Global Immune Thrombocytopenia Drugs Forecasted Market Size by Type (2025-2030)

5 Immune Thrombocytopenia Drugs Breakdown Data by Application

5.1 Global Immune Thrombocytopenia Drugs Historic Market Size by Application (2019-2024)

5.2 Global Immune Thrombocytopenia Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Immune Thrombocytopenia Drugs Market Size (2019-2030)

6.2 North America Immune Thrombocytopenia Drugs Market Size by Type

6.2.1 North America Immune Thrombocytopenia Drugs Market Size by Type (2019-2024)

6.2.2 North America Immune Thrombocytopenia Drugs Market Size by Type (2025-2030)

6.2.3 North America Immune Thrombocytopenia Drugs Market Share by Type (2019-2030)

6.3 North America Immune Thrombocytopenia Drugs Market Size by Application

6.3.1 North America Immune Thrombocytopenia Drugs Market Size by Application (2019-2024)

6.3.2 North America Immune Thrombocytopenia Drugs Market Size by Application (2025-2030)

6.3.3 North America Immune Thrombocytopenia Drugs Market Share by Application (2019-2030)

6.4 North America Immune Thrombocytopenia Drugs Market Size by Country

6.4.1 North America Immune Thrombocytopenia Drugs Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Immune Thrombocytopenia Drugs Market Size by Country (2019-2024)

6.4.3 North America Immune Thrombocytopenia Drugs Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Immune Thrombocytopenia Drugs Market Size (2019-2030)

7.2 Europe Immune Thrombocytopenia Drugs Market Size by Type

7.2.1 Europe Immune Thrombocytopenia Drugs Market Size by Type (2019-2024)

7.2.2 Europe Immune Thrombocytopenia Drugs Market Size by Type (2025-2030)

7.2.3 Europe Immune Thrombocytopenia Drugs Market Share by Type (2019-2030)

7.3 Europe Immune Thrombocytopenia Drugs Market Size by Application

7.3.1 Europe Immune Thrombocytopenia Drugs Market Size by Application (2019-2024)

7.3.2 Europe Immune Thrombocytopenia Drugs Market Size by Application (2025-2030)

7.3.3 Europe Immune Thrombocytopenia Drugs Market Share by Application (2019-2030)

7.4 Europe Immune Thrombocytopenia Drugs Market Size by Country

7.4.1 Europe Immune Thrombocytopenia Drugs Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Immune Thrombocytopenia Drugs Market Size by Country (2019-2024)

7.4.3 Europe Immune Thrombocytopenia Drugs Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Immune Thrombocytopenia Drugs Market Size (2019-2030)

8.2 China Immune Thrombocytopenia Drugs Market Size by Type

8.2.1 China Immune Thrombocytopenia Drugs Market Size by Type (2019-2024)

8.2.2 China Immune Thrombocytopenia Drugs Market Size by Type (2025-2030)

8.2.3 China Immune Thrombocytopenia Drugs Market Share by Type (2019-2030)

8.3 China Immune Thrombocytopenia Drugs Market Size by Application

8.3.1 China Immune Thrombocytopenia Drugs Market Size by Application (2019-2024)

8.3.2 China Immune Thrombocytopenia Drugs Market Size by Application (2025-2030)

8.3.3 China Immune Thrombocytopenia Drugs Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Immune Thrombocytopenia Drugs Market Size (2019-2030)

9.2 Asia Immune Thrombocytopenia Drugs Market Size by Type

9.2.1 Asia Immune Thrombocytopenia Drugs Market Size by Type (2019-2024)

9.2.2 Asia Immune Thrombocytopenia Drugs Market Size by Type (2025-2030)

9.2.3 Asia Immune Thrombocytopenia Drugs Market Share by Type (2019-2030)

9.3 Asia Immune Thrombocytopenia Drugs Market Size by Application

9.3.1 Asia Immune Thrombocytopenia Drugs Market Size by Application (2019-2024)

9.3.2 Asia Immune Thrombocytopenia Drugs Market Size by Application (2025-2030)

9.3.3 Asia Immune Thrombocytopenia Drugs Market Share by Application (2019-2030)

9.4 Asia Immune Thrombocytopenia Drugs Market Size by Region

9.4.1 Asia Immune Thrombocytopenia Drugs Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Immune Thrombocytopenia Drugs Market Size by Region (2019-2024)

9.4.3 Asia Immune Thrombocytopenia Drugs Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Type

10.2.1 Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Application

10.3.1 Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Country

10.4.1 Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Amgen Inc.

11.1.1 Amgen Inc. Company Details

11.1.2 Amgen Inc. Business Overview

11.1.3 Amgen Inc. Immune Thrombocytopenia Drugs Introduction

11.1.4 Amgen Inc. Revenue in Immune Thrombocytopenia Drugs Business (2019-2024)

11.1.5 Amgen Inc. Recent Developments

11.2 CSL Ltd.

11.2.1 CSL Ltd. Company Details

11.2.2 CSL Ltd. Business Overview

11.2.3 CSL Ltd. Immune Thrombocytopenia Drugs Introduction

11.2.4 CSL Ltd. Revenue in Immune Thrombocytopenia Drugs Business (2019-2024)

11.2.5 CSL Ltd. Recent Developments

11.3 Horizon Therapeutics Plc

11.3.1 Horizon Therapeutics Plc Company Details

11.3.2 Horizon Therapeutics Plc Business Overview

11.3.3 Horizon Therapeutics Plc Immune Thrombocytopenia Drugs Introduction

11.3.4 Horizon Therapeutics Plc Revenue in Immune Thrombocytopenia Drugs Business (2019-2024)

11.3.5 Horizon Therapeutics Plc Recent Developments

11.4 Merck & Co., Inc.

11.4.1 Merck & Co., Inc. Company Details

11.4.2 Merck & Co., Inc. Business Overview

11.4.3 Merck & Co., Inc. Immune Thrombocytopenia Drugs Introduction

11.4.4 Merck & Co., Inc. Revenue in Immune Thrombocytopenia Drugs Business (2019-2024)

11.4.5 Merck & Co., Inc. Recent Developments

11.5 Novartis AG

11.5.1 Novartis AG Company Details

11.5.2 Novartis AG Business Overview

11.5.3 Novartis AG Immune Thrombocytopenia Drugs Introduction

11.5.4 Novartis AG Revenue in Immune Thrombocytopenia Drugs Business (2019-2024)

11.5.5 Novartis AG Recent Developments

11.6 Rigel Pharmaceuticals Inc.

11.6.1 Rigel Pharmaceuticals Inc. Company Details

11.6.2 Rigel Pharmaceuticals Inc. Business Overview

11.6.3 Rigel Pharmaceuticals Inc. Immune Thrombocytopenia Drugs Introduction

11.6.4 Rigel Pharmaceuticals Inc. Revenue in Immune Thrombocytopenia Drugs Business (2019-2024)

11.6.5 Rigel Pharmaceuticals Inc. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Amgen Inc

CSL Limited

Horizon Therapeutics plc

Merck& Co. Inc

Novartis

Rigel Pharmaceuticals Inc

List of Tables

Table 1. Global Immune Thrombocytopenia Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Thrombopoietin Receptor Agonists (TPO-RAs)

Table 3. Key Players of Corticosteroids

Table 4. Key Players of Intravenous Immunoglobins (IVIGs)

Table 5. Key Players of Other Drugs

Table 6. Global Immune Thrombocytopenia Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Immune Thrombocytopenia Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Immune Thrombocytopenia Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Immune Thrombocytopenia Drugs Market Share by Region (2019-2024)

Table 10. Global Immune Thrombocytopenia Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Immune Thrombocytopenia Drugs Market Share by Region (2025-2030)

Table 12. Immune Thrombocytopenia Drugs Market Trends

Table 13. Immune Thrombocytopenia Drugs Market Drivers

Table 14. Immune Thrombocytopenia Drugs Market Challenges

Table 15. Immune Thrombocytopenia Drugs Market Restraints

Table 16. Global Immune Thrombocytopenia Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Immune Thrombocytopenia Drugs Revenue Share by Players (2019-2024)

Table 18. Global Top Immune Thrombocytopenia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Thrombocytopenia Drugs as of 2023)

Table 19. Global Immune Thrombocytopenia Drugs Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Immune Thrombocytopenia Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Immune Thrombocytopenia Drugs, Headquarters and Area Served

Table 22. Global Key Players of Immune Thrombocytopenia Drugs, Product and Application

Table 23. Global Key Players of Immune Thrombocytopenia Drugs, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Immune Thrombocytopenia Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Immune Thrombocytopenia Drugs Revenue Market Share by Type (2019-2024)

Table 27. Global Immune Thrombocytopenia Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Immune Thrombocytopenia Drugs Revenue Market Share by Type (2025-2030)

Table 29. Global Immune Thrombocytopenia Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Immune Thrombocytopenia Drugs Revenue Share by Application (2019-2024)

Table 31. Global Immune Thrombocytopenia Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Immune Thrombocytopenia Drugs Revenue Share by Application (2025-2030)

Table 33. North America Immune Thrombocytopenia Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Immune Thrombocytopenia Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Immune Thrombocytopenia Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Immune Thrombocytopenia Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Immune Thrombocytopenia Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Immune Thrombocytopenia Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Immune Thrombocytopenia Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Immune Thrombocytopenia Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Immune Thrombocytopenia Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Immune Thrombocytopenia Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Immune Thrombocytopenia Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Immune Thrombocytopenia Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Immune Thrombocytopenia Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Immune Thrombocytopenia Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Immune Thrombocytopenia Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Immune Thrombocytopenia Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Immune Thrombocytopenia Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Immune Thrombocytopenia Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Immune Thrombocytopenia Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Immune Thrombocytopenia Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Immune Thrombocytopenia Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Immune Thrombocytopenia Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Immune Thrombocytopenia Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Immune Thrombocytopenia Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Immune Thrombocytopenia Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 65. Amgen Inc. Company Details

Table 66. Amgen Inc. Business Overview

Table 67. Amgen Inc. Immune Thrombocytopenia Drugs Product

Table 68. Amgen Inc. Revenue in Immune Thrombocytopenia Drugs Business (2019-2024) & (US$ Million)

Table 69. Amgen Inc. Recent Developments

Table 70. CSL Ltd. Company Details

Table 71. CSL Ltd. Business Overview

Table 72. CSL Ltd. Immune Thrombocytopenia Drugs Product

Table 73. CSL Ltd. Revenue in Immune Thrombocytopenia Drugs Business (2019-2024) & (US$ Million)

Table 74. CSL Ltd. Recent Developments

Table 75. Horizon Therapeutics Plc Company Details

Table 76. Horizon Therapeutics Plc Business Overview

Table 77. Horizon Therapeutics Plc Immune Thrombocytopenia Drugs Product

Table 78. Horizon Therapeutics Plc Revenue in Immune Thrombocytopenia Drugs Business (2019-2024) & (US$ Million)

Table 79. Horizon Therapeutics Plc Recent Developments

Table 80. Merck & Co., Inc. Company Details

Table 81. Merck & Co., Inc. Business Overview

Table 82. Merck & Co., Inc. Immune Thrombocytopenia Drugs Product

Table 83. Merck & Co., Inc. Revenue in Immune Thrombocytopenia Drugs Business (2019-2024) & (US$ Million)

Table 84. Merck & Co., Inc. Recent Developments

Table 85. Novartis AG Company Details

Table 86. Novartis AG Business Overview

Table 87. Novartis AG Immune Thrombocytopenia Drugs Product

Table 88. Novartis AG Revenue in Immune Thrombocytopenia Drugs Business (2019-2024) & (US$ Million)

Table 89. Novartis AG Recent Developments

Table 90. Rigel Pharmaceuticals Inc. Company Details

Table 91. Rigel Pharmaceuticals Inc. Business Overview

Table 92. Rigel Pharmaceuticals Inc. Immune Thrombocytopenia Drugs Product

Table 93. Rigel Pharmaceuticals Inc. Revenue in Immune Thrombocytopenia Drugs Business (2019-2024) & (US$ Million)

Table 94. Rigel Pharmaceuticals Inc. Recent Developments

Table 95. Research Programs/Design for This Report

Table 96. Key Data Information from Secondary Sources

Table 97. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Immune Thrombocytopenia Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Immune Thrombocytopenia Drugs Market Share by Type: 2023 VS 2030

Figure 3. Thrombopoietin Receptor Agonists (TPO-RAs) Features

Figure 4. Corticosteroids Features

Figure 5. Intravenous Immunoglobins (IVIGs) Features

Figure 6. Other Drugs Features

Figure 7. Global Immune Thrombocytopenia Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Immune Thrombocytopenia Drugs Market Share by Application: 2023 VS 2030

Figure 9. Biotechnology and Pharmaceutical Companies Case Studies

Figure 10. Hospitals and Diagnostic Centers Case Studies

Figure 11. Academic Institutes and Research Organizations Case Studies

Figure 12. Immune Thrombocytopenia Drugs Report Years Considered

Figure 13. Global Immune Thrombocytopenia Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Immune Thrombocytopenia Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Immune Thrombocytopenia Drugs Market Share by Region: 2023 VS 2030

Figure 16. Global Immune Thrombocytopenia Drugs Market Share by Players in 2023

Figure 17. Global Top Immune Thrombocytopenia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Thrombocytopenia Drugs as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Immune Thrombocytopenia Drugs Revenue in 2023

Figure 19. North America Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Immune Thrombocytopenia Drugs Market Share by Type (2019-2030)

Figure 21. North America Immune Thrombocytopenia Drugs Market Share by Application (2019-2030)

Figure 22. North America Immune Thrombocytopenia Drugs Market Share by Country (2019-2030)

Figure 23. United States Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Immune Thrombocytopenia Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Immune Thrombocytopenia Drugs Market Share by Type (2019-2030)

Figure 27. Europe Immune Thrombocytopenia Drugs Market Share by Application (2019-2030)

Figure 28. Europe Immune Thrombocytopenia Drugs Market Share by Country (2019-2030)

Figure 29. Germany Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Immune Thrombocytopenia Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Immune Thrombocytopenia Drugs Market Share by Type (2019-2030)

Figure 37. China Immune Thrombocytopenia Drugs Market Share by Application (2019-2030)

Figure 38. Asia Immune Thrombocytopenia Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Immune Thrombocytopenia Drugs Market Share by Type (2019-2030)

Figure 40. Asia Immune Thrombocytopenia Drugs Market Share by Application (2019-2030)

Figure 41. Asia Immune Thrombocytopenia Drugs Market Share by Region (2019-2030)

Figure 42. Japan Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Immune Thrombocytopenia Drugs Market Share by Country (2019-2030)

Figure 52. Brazil Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Immune Thrombocytopenia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Amgen Inc. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2019-2024)

Figure 59. CSL Ltd. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2019-2024)

Figure 60. Horizon Therapeutics Plc Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2019-2024)

Figure 61. Merck & Co., Inc. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2019-2024)

Figure 62. Novartis AG Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2019-2024)

Figure 63. Rigel Pharmaceuticals Inc. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2019-2024)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions